This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009 Apr;37(3):363-71.

doi: 10.1177/0192623309332997. Epub 2009 Feb 26.

The EMEA guideline on first-in-human clinical trials and its impact on pharmaceutical development

Mark N Milton¹, Christopher J Horvath

Affiliations

PMID: 19246571
DOI: 10.1177/0192623309332997

The EMEA guideline on first-in-human clinical trials and its impact on pharmaceutical development

Mark N Milton et al. Toxicol Pathol. 2009 Apr.

. 2009 Apr;37(3):363-71.

doi: 10.1177/0192623309332997. Epub 2009 Feb 26.

Authors

Mark N Milton¹, Christopher J Horvath

Affiliation

¹ Tempo Pharmaceuticals, Cambridge, Massachusetts 02142, USA. mnmilt@gmail.com

PMID: 19246571
DOI: 10.1177/0192623309332997

No abstract available

PubMed Disclaimer

Similar articles

The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials.
Marchetti S, Schellens JH. Marchetti S, et al. Br J Cancer. 2007 Sep 3;97(5):577-81. doi: 10.1038/sj.bjc.6603925. Epub 2007 Aug 28. Br J Cancer. 2007. PMID: 17726450 Free PMC article. Review.
Promoting, improving and accelerating the drug development and approval processes.
Graul AI. Graul AI. Drug News Perspect. 2007 Jan-Feb;20(1):45-55. Drug News Perspect. 2007. PMID: 17332899
Promoting, improving and accelerating the drug development and approval processes.
Graul AI. Graul AI. Drug News Perspect. 2009 Jan-Feb;22(1):30-8. doi: 10.1358/dnp.2009.22.1.1303816. Drug News Perspect. 2009. PMID: 19209297
"Getting the dose right": facts, a blueprint, and encouragements.
Peck CC, Cross JT. Peck CC, et al. Clin Pharmacol Ther. 2007 Jul;82(1):12-4. doi: 10.1038/sj.clpt.6100215. Clin Pharmacol Ther. 2007. PMID: 17571068 No abstract available.
The draft FDA guideline on non-inferiority clinical trials: a critical review from European pharmaceutical industry statisticians.
Huitfeldt B, Hummel J; European Federation of Statisticians in the Pharmaceutical Industry (EFSPI). Huitfeldt B, et al. Pharm Stat. 2011 Sep-Oct;10(5):414-9. doi: 10.1002/pst.508. Epub 2011 Sep 19. Pharm Stat. 2011. PMID: 21932294 Review.

See all similar articles

Cited by

Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials.
Hansen AR, Cook N, Ricci MS, Razak A, Le Tourneau C, McKeever K, Roskos L, Dixit R, Siu LL, Hinrichs MJ. Hansen AR, et al. Oncologist. 2015 Jun;20(6):653-9. doi: 10.1634/theoncologist.2015-0008. Epub 2015 May 11. Oncologist. 2015. PMID: 25964306 Free PMC article.
A review of dose escalation for FDA-approved products treating solid tumors and hematological malignancies in first-in-human trials.
Jiang Z, Sun W, Du R, Yang R. Jiang Z, et al. Clin Transl Oncol. 2024 Sep;26(9):2116-2125. doi: 10.1007/s12094-024-03451-2. Epub 2024 Apr 1. Clin Transl Oncol. 2024. PMID: 38558284 Review.
Sentinel dosing: A proposed algorithm to guide decision making on which cohorts in early phase clinical pharmacology trials should use this approach.
Heuberger JAAC, de Jongh P, van Hoogdalem EJ, Tamminga W, de Graeff P, Groeneveld GJ. Heuberger JAAC, et al. Br J Clin Pharmacol. 2025 Sep;91(9):2705-2710. doi: 10.1002/bcp.70090. Epub 2025 May 15. Br J Clin Pharmacol. 2025. PMID: 40370057 Free PMC article.
Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013.
Suh HY, Peck CC, Yu KS, Lee H. Suh HY, et al. Drug Des Devel Ther. 2016 Dec 8;10:4005-4016. doi: 10.2147/DDDT.S121520. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27994442 Free PMC article.
Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia.
Alsultan A, Alghamdi WA, Alghamdi J, Alharbi AF, Aljutayli A, Albassam A, Almazroo O, Alqahtani S. Alsultan A, et al. Saudi Pharm J. 2020 Oct;28(10):1217-1227. doi: 10.1016/j.jsps.2020.08.012. Epub 2020 Aug 21. Saudi Pharm J. 2020. PMID: 33132716 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information